COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,301 Articles (22,772 medRxiv, 8,529 bioRxiv)

Most recent first Previous |  Page 1317: Articles 13161-13170  | Next

Reducing false reassurance following negative results from asymptomatic coronavirus (Covid-19) testing: an online experiment
Batteux, E., Bonfield, S., Jones, L. F., Carter, H., Gold, N., Amlot, R., Marteau, T. M., Weston, D.
10.1101/2021.08.03.21261482 — Posted: 2021-08-10
The effect of eye protection on SARS-CoV-2 transmission: a systematic review
Byambasuren, O., Beller, E., Clark, J., Collignon, P., Glasziou, P.
10.1101/2021.08.08.21261770 — Posted: 2021-08-09
A Systematic Comparison of Differential Analysis Methods for CyTOF Data
Arend, L., Bernett, J., Manz, Q., Klug, M., Lazareva, O., Baumbach, J., Bongiovanni, D., List, M.
10.1101/2021.08.09.455609 — Posted: 2021-08-09
A broadly neutralizing biparatopic Nanobody protects mice from lethal challenge with SARS-CoV-2 variants of concern
Wagner, T. R., Schnepf, D., Beer, J., Klingel, K., Ruetalo, N., Kaiser, P. D., Junker, D., Sauter, M., Traenkle, B., Frecot, D. I., Becker, M., Schneiderhan-Marra, N., Ohnemus, A., Schwemmle, M., Schindler, M., Rothbauer, U.
10.1101/2021.08.08.455562 — Posted: 2021-08-09
A Tethered Ligand Assay to Probe SARS-CoV-2:ACE2 Interactions
Bauer, M. S., Gruber, S., Hausch, A., Milles, L. F., Nicolaus, T., Schendel, L. C., Lopez Navajas, P., Procko, E., Lietha, D., Bernardi, R. C., Gaub, H. E., Lipfert, J.
10.1101/2021.08.08.455468 — Posted: 2021-08-09
Reprogramming of the intestinal epithelial-immune cell interactome during SARS-CoV-2 infection
Poletti, M., Treveil, A., Gul, L., Modos, D., Madgwick, M., Olbei, M., Bohar, B., Valdeolivas, A., Turei, D., Verstockt, B., Triana, S., Alexandrov, T., Saez-Rodriguez, J., Stanifer, M. L., Boulant, S., Korcsmaros, T.
10.1101/2021.08.09.455656 — Posted: 2021-08-09
Broad neutralizing nanobody against SARS-CoV-2 engineered from pre-designed synthetic library
Liu, Q., Cai, C., Huang, Y., Zhou, L., Guan, Y., Fu, S., Lin, Y., Yang, T., Liang, X., Wang, N., Zhang, F., Sun, Q., Bai, Y., Chen, Y., Yan, H., Zhang, Z., Lan, K., Chen, Y., Li, X., Hou, S.-C., Xiong, Y.
10.1101/2021.08.07.455523 — Posted: 2021-08-09
Fully Human Antibody Immunoglobulin from Transchromosomic Bovines is Potent Against SARS-CoV-2 Variant Pseudoviruses
Luke, T., Wu, H., Egland, K. A., Sullivan, E. J., Bausch, C. L.
10.1101/2021.08.09.454215 — Posted: 2021-08-09
ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology
Gawish, R., Starkl, P., Pimenov, L., Hladik, A., Lakovits, K., Oberndorfer, F., Cronin, S. J. F., Ohradanova-Repic, A., Wirnsberger, G., Agerer, B., Endler, L., Capraz, T., Perthold, J. W., Hagelkruys, A., Montserrat, N., Mirazimi, A., Boon, L., Stockinger, H., Bergthaler, A., Oostenbrink, C., Penninger, J. M., Knapp, S.
10.1101/2021.08.09.455606 — Posted: 2021-08-09
High vaccine effectiveness against COVID-19 infection and severe disease among residents and staff of long-term care facilities in Norway, November - June 2021
Starrfelt, J., Danielsen, A. S., Kacelnik, O., Borseth, A. W., Seppala, E., Meijerink, H.
10.1101/2021.08.08.21261357 — Posted: 2021-08-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).